These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12221904)

  • 1. Effects of fluvastatin on homocysteine and serum lipids in kidney allograft recipients.
    Małyszko J; Małyszko JS; Brzósko S; Pawlak K; Myśliwiec M
    Ann Transplant; 2002; 7(1):52-4. PubMed ID: 12221904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.
    Türk S; Yildiz A; Tükek T; Akkaya V; Aras U; Türkmen A; Uras AR; Sever MS
    Int Urol Nephrol; 2001; 32(4):713-6. PubMed ID: 11989571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
    Holdaas H; Fellström B; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Solbu DO; Pedersen TR;
    Lancet; 2003 Jun; 361(9374):2024-31. PubMed ID: 12814712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of fluvastatin on progressive renal allograft dysfunction.
    Konstadinidou I; Boletis JN; Perrea D; Triantafyllou A; Filiopoulos V; Stamataki E; Kostakis A; Stathakis ChP
    Transplant Proc; 2003 Jun; 35(4):1364-7. PubMed ID: 12826160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation.
    Asberg A; Holdaas H; Jardine AG; Edvardsen C; Hartmann A
    Clin Transplant; 2003 Aug; 17(4):385-90. PubMed ID: 12868997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metabolic disorders with fluvastatin after renal transplantation.
    Podder H; Gerõ L; Földes K; Szabó J; Lazar N; Járay J
    Transplant Proc; 1997; 29(1-2):216-9. PubMed ID: 9122968
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients.
    Melchor JL; Gracida C
    Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid-lowering effects of fluvastatin in renal transplant patients. A clinical observation.
    Lal SM; Gupta N; Georgiev O; Ross G
    Int J Artif Organs; 1997 Jan; 20(1):18-21. PubMed ID: 9062827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum lipids when fluvastatin is substituted for lovastatin in the same doses.
    Rindone JP; Arriola G; Hiller D; Achacoso R
    Am J Cardiol; 1997 Aug; 80(3):348-9. PubMed ID: 9264434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Logan JO; Pedersen TR;
    Kidney Int; 2004 Oct; 66(4):1549-55. PubMed ID: 15458450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
    Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
    Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.